Report Detail

Pharma & Healthcare Global and Japan Orthobiologics Market Size, Status and Forecast 2020-2026

  • RnM4182846
  • |
  • 02 September, 2020
  • |
  • Global
  • |
  • 134 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Orthobiologics Scope and Market Size
Orthobiologics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Orthobiologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Bone Growth Stimulators (BGS)
Viscosupplements
Bone Graft Substitute

Market segment by Application, split into
Hospitals
Ambulatory Surgical Centres
Orthopaedics Clinics

Based on regional and country-level analysis, the Orthobiologics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Orthobiologics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Medtronic
NuVasive, Inc.
Stryker Corporation
Zimmer Biomet Holdings
Orthofix International N.V.
Anika Therapeutics, Inc.
DePuy Synthes (Johnson & Johnson)
Bioventus
Arthrex, Inc.
SeaSpine Holdings Corporation
Sanofi-Aventis (Sanofi SA)
Djo Global, Inc.
Seikagaku Corporation
RTI Surgical, Inc.
Heraeus Holding GmbH
Fidia Pharma USA Inc.
TRB Chemedica International SA
Allosource
Musculoskeletal Transplant Foundation, Inc.
Ito


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Orthobiologics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Bone Growth Stimulators (BGS)
    • 1.2.3 Viscosupplements
    • 1.2.4 Bone Graft Substitute
  • 1.3 Market by Application
    • 1.3.1 Global Orthobiologics Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospitals
    • 1.3.3 Ambulatory Surgical Centres
    • 1.3.4 Orthopaedics Clinics
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Orthobiologics Market Perspective (2015-2026)
  • 2.2 Global Orthobiologics Growth Trends by Regions
    • 2.2.1 Orthobiologics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Orthobiologics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Orthobiologics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Orthobiologics Players by Market Size
    • 3.1.1 Global Top Orthobiologics Players by Revenue (2015-2020)
    • 3.1.2 Global Orthobiologics Revenue Market Share by Players (2015-2020)
  • 3.2 Global Orthobiologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Orthobiologics Revenue
  • 3.4 Global Orthobiologics Market Concentration Ratio
    • 3.4.1 Global Orthobiologics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Orthobiologics Revenue in 2019
  • 3.5 Key Players Orthobiologics Area Served
  • 3.6 Key Players Orthobiologics Product Solution and Service
  • 3.7 Date of Enter into Orthobiologics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Orthobiologics Breakdown Data by Type (2015-2026)

  • 4.1 Global Orthobiologics Historic Market Size by Type (2015-2020)
  • 4.2 Global Orthobiologics Forecasted Market Size by Type (2021-2026)

5 Orthobiologics Breakdown Data by Application (2015-2026)

  • 5.1 Global Orthobiologics Historic Market Size by Application (2015-2020)
  • 5.2 Global Orthobiologics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Orthobiologics Market Size (2015-2026)
  • 6.2 North America Orthobiologics Market Size by Type (2015-2020)
  • 6.3 North America Orthobiologics Market Size by Application (2015-2020)
  • 6.4 North America Orthobiologics Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Orthobiologics Market Size (2015-2026)
  • 7.2 Europe Orthobiologics Market Size by Type (2015-2020)
  • 7.3 Europe Orthobiologics Market Size by Application (2015-2020)
  • 7.4 Europe Orthobiologics Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Orthobiologics Market Size (2015-2026)
  • 8.2 China Orthobiologics Market Size by Type (2015-2020)
  • 8.3 China Orthobiologics Market Size by Application (2015-2020)
  • 8.4 China Orthobiologics Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Orthobiologics Market Size (2015-2026)
  • 9.2 Japan Orthobiologics Market Size by Type (2015-2020)
  • 9.3 Japan Orthobiologics Market Size by Application (2015-2020)
  • 9.4 Japan Orthobiologics Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Orthobiologics Market Size (2015-2026)
  • 10.2 Southeast Asia Orthobiologics Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Orthobiologics Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Orthobiologics Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Medtronic
    • 11.1.1 Medtronic Company Details
    • 11.1.2 Medtronic Business Overview
    • 11.1.3 Medtronic Orthobiologics Introduction
    • 11.1.4 Medtronic Revenue in Orthobiologics Business (2015-2020))
    • 11.1.5 Medtronic Recent Development
  • 11.2 NuVasive, Inc.
    • 11.2.1 NuVasive, Inc. Company Details
    • 11.2.2 NuVasive, Inc. Business Overview
    • 11.2.3 NuVasive, Inc. Orthobiologics Introduction
    • 11.2.4 NuVasive, Inc. Revenue in Orthobiologics Business (2015-2020)
    • 11.2.5 NuVasive, Inc. Recent Development
  • 11.3 Stryker Corporation
    • 11.3.1 Stryker Corporation Company Details
    • 11.3.2 Stryker Corporation Business Overview
    • 11.3.3 Stryker Corporation Orthobiologics Introduction
    • 11.3.4 Stryker Corporation Revenue in Orthobiologics Business (2015-2020)
    • 11.3.5 Stryker Corporation Recent Development
  • 11.4 Zimmer Biomet Holdings
    • 11.4.1 Zimmer Biomet Holdings Company Details
    • 11.4.2 Zimmer Biomet Holdings Business Overview
    • 11.4.3 Zimmer Biomet Holdings Orthobiologics Introduction
    • 11.4.4 Zimmer Biomet Holdings Revenue in Orthobiologics Business (2015-2020)
    • 11.4.5 Zimmer Biomet Holdings Recent Development
  • 11.5 Orthofix International N.V.
    • 11.5.1 Orthofix International N.V. Company Details
    • 11.5.2 Orthofix International N.V. Business Overview
    • 11.5.3 Orthofix International N.V. Orthobiologics Introduction
    • 11.5.4 Orthofix International N.V. Revenue in Orthobiologics Business (2015-2020)
    • 11.5.5 Orthofix International N.V. Recent Development
  • 11.6 Anika Therapeutics, Inc.
    • 11.6.1 Anika Therapeutics, Inc. Company Details
    • 11.6.2 Anika Therapeutics, Inc. Business Overview
    • 11.6.3 Anika Therapeutics, Inc. Orthobiologics Introduction
    • 11.6.4 Anika Therapeutics, Inc. Revenue in Orthobiologics Business (2015-2020)
    • 11.6.5 Anika Therapeutics, Inc. Recent Development
  • 11.7 DePuy Synthes (Johnson & Johnson)
    • 11.7.1 DePuy Synthes (Johnson & Johnson) Company Details
    • 11.7.2 DePuy Synthes (Johnson & Johnson) Business Overview
    • 11.7.3 DePuy Synthes (Johnson & Johnson) Orthobiologics Introduction
    • 11.7.4 DePuy Synthes (Johnson & Johnson) Revenue in Orthobiologics Business (2015-2020)
    • 11.7.5 DePuy Synthes (Johnson & Johnson) Recent Development
  • 11.8 Bioventus
    • 11.8.1 Bioventus Company Details
    • 11.8.2 Bioventus Business Overview
    • 11.8.3 Bioventus Orthobiologics Introduction
    • 11.8.4 Bioventus Revenue in Orthobiologics Business (2015-2020)
    • 11.8.5 Bioventus Recent Development
  • 11.9 Arthrex, Inc.
    • 11.9.1 Arthrex, Inc. Company Details
    • 11.9.2 Arthrex, Inc. Business Overview
    • 11.9.3 Arthrex, Inc. Orthobiologics Introduction
    • 11.9.4 Arthrex, Inc. Revenue in Orthobiologics Business (2015-2020)
    • 11.9.5 Arthrex, Inc. Recent Development
  • 11.10 SeaSpine Holdings Corporation
    • 11.10.1 SeaSpine Holdings Corporation Company Details
    • 11.10.2 SeaSpine Holdings Corporation Business Overview
    • 11.10.3 SeaSpine Holdings Corporation Orthobiologics Introduction
    • 11.10.4 SeaSpine Holdings Corporation Revenue in Orthobiologics Business (2015-2020)
    • 11.10.5 SeaSpine Holdings Corporation Recent Development
  • 11.11 Sanofi-Aventis (Sanofi SA)
    • 10.11.1 Sanofi-Aventis (Sanofi SA) Company Details
    • 10.11.2 Sanofi-Aventis (Sanofi SA) Business Overview
    • 10.11.3 Sanofi-Aventis (Sanofi SA) Orthobiologics Introduction
    • 10.11.4 Sanofi-Aventis (Sanofi SA) Revenue in Orthobiologics Business (2015-2020)
    • 10.11.5 Sanofi-Aventis (Sanofi SA) Recent Development
  • 11.12 Djo Global, Inc.
    • 10.12.1 Djo Global, Inc. Company Details
    • 10.12.2 Djo Global, Inc. Business Overview
    • 10.12.3 Djo Global, Inc. Orthobiologics Introduction
    • 10.12.4 Djo Global, Inc. Revenue in Orthobiologics Business (2015-2020)
    • 10.12.5 Djo Global, Inc. Recent Development
  • 11.13 Seikagaku Corporation
    • 10.13.1 Seikagaku Corporation Company Details
    • 10.13.2 Seikagaku Corporation Business Overview
    • 10.13.3 Seikagaku Corporation Orthobiologics Introduction
    • 10.13.4 Seikagaku Corporation Revenue in Orthobiologics Business (2015-2020)
    • 10.13.5 Seikagaku Corporation Recent Development
  • 11.14 RTI Surgical, Inc.
    • 10.14.1 RTI Surgical, Inc. Company Details
    • 10.14.2 RTI Surgical, Inc. Business Overview
    • 10.14.3 RTI Surgical, Inc. Orthobiologics Introduction
    • 10.14.4 RTI Surgical, Inc. Revenue in Orthobiologics Business (2015-2020)
    • 10.14.5 RTI Surgical, Inc. Recent Development
  • 11.15 Heraeus Holding GmbH
    • 10.15.1 Heraeus Holding GmbH Company Details
    • 10.15.2 Heraeus Holding GmbH Business Overview
    • 10.15.3 Heraeus Holding GmbH Orthobiologics Introduction
    • 10.15.4 Heraeus Holding GmbH Revenue in Orthobiologics Business (2015-2020)
    • 10.15.5 Heraeus Holding GmbH Recent Development
  • 11.16 Fidia Pharma USA Inc.
    • 10.16.1 Fidia Pharma USA Inc. Company Details
    • 10.16.2 Fidia Pharma USA Inc. Business Overview
    • 10.16.3 Fidia Pharma USA Inc. Orthobiologics Introduction
    • 10.16.4 Fidia Pharma USA Inc. Revenue in Orthobiologics Business (2015-2020)
    • 10.16.5 Fidia Pharma USA Inc. Recent Development
  • 11.17 TRB Chemedica International SA
    • 10.17.1 TRB Chemedica International SA Company Details
    • 10.17.2 TRB Chemedica International SA Business Overview
    • 10.17.3 TRB Chemedica International SA Orthobiologics Introduction
    • 10.17.4 TRB Chemedica International SA Revenue in Orthobiologics Business (2015-2020)
    • 10.17.5 TRB Chemedica International SA Recent Development
  • 11.18 Allosource
    • 10.18.1 Allosource Company Details
    • 10.18.2 Allosource Business Overview
    • 10.18.3 Allosource Orthobiologics Introduction
    • 10.18.4 Allosource Revenue in Orthobiologics Business (2015-2020)
    • 10.18.5 Allosource Recent Development
  • 11.19 Musculoskeletal Transplant Foundation, Inc.
    • 10.19.1 Musculoskeletal Transplant Foundation, Inc. Company Details
    • 10.19.2 Musculoskeletal Transplant Foundation, Inc. Business Overview
    • 10.19.3 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Introduction
    • 10.19.4 Musculoskeletal Transplant Foundation, Inc. Revenue in Orthobiologics Business (2015-2020)
    • 10.19.5 Musculoskeletal Transplant Foundation, Inc. Recent Development
  • 11.20 Ito
    • 10.20.1 Ito Company Details
    • 10.20.2 Ito Business Overview
    • 10.20.3 Ito Orthobiologics Introduction
    • 10.20.4 Ito Revenue in Orthobiologics Business (2015-2020)
    • 10.20.5 Ito Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Summary:
    Get latest Market Research Reports on Orthobiologics. Industry analysis & Market Report on Orthobiologics is a syndicated market report, published as Global and Japan Orthobiologics Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Orthobiologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,108.30
    4,662.45
    6,216.60
    3,623.10
    5,434.65
    7,246.20
    596,427.00
    894,640.50
    1,192,854.00
    325,338.00
    488,007.00
    650,676.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report